Suchergebnisse - "Bigaut, Kévin"

PubPharm (5)

1

Early use of high efficacy therapies in pediatric forms of relapsing-remitting multiple sclerosis : A real-life observational study

enthalten in: Multiple sclerosis and related disorders | 2023

von Moreau, A. | Kolitsi, I. | Kremer, L. | +12

2

Post-vaccine COVID-19 in patients with multiple sclerosis or neuromyelitis optica

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2022

von Januel, E. | De Seze, J. | Vermersch, P. | +23

3

Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis : an observational study

enthalten in: Journal of neurology | 2022

von Bigaut, K. | Kremer, L. | Fabacher, T. | +7

4

BEST-MS : A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2021

von Cohen, M. | Mondot, L. | Bucciarelli, F. | +19

5

How to switch disease-modifying treatments in multiple sclerosis : Guidelines from the French Multiple Sclerosis Society (SFSEP)

enthalten in: Multiple sclerosis and related disorders | 2021

von Bigaut, K. | Cohen, M. | Durand-Dubief, F. | +6

1
[1]